204 related articles for article (PubMed ID: 12115612)
1. Comparison of CD22 binding to native CD45 and synthetic oligosaccharide.
Bakker TR; Piperi C; Davies EA; Merwe PA
Eur J Immunol; 2002 Jul; 32(7):1924-32. PubMed ID: 12115612
[TBL] [Abstract][Full Text] [Related]
2. Localization of the putative sialic acid-binding site on the immunoglobulin superfamily cell-surface molecule CD22.
van der Merwe PA; Crocker PR; Vinson M; Barclay AN; Schauer R; Kelm S
J Biol Chem; 1996 Apr; 271(16):9273-80. PubMed ID: 8621588
[TBL] [Abstract][Full Text] [Related]
3. Natural ligands of the B cell adhesion molecule CD22 beta carry N-linked oligosaccharides with alpha-2,6-linked sialic acids that are required for recognition.
Powell LD; Sgroi D; Sjoberg ER; Stamenkovic I; Varki A
J Biol Chem; 1993 Apr; 268(10):7019-27. PubMed ID: 8463235
[TBL] [Abstract][Full Text] [Related]
4. Differential control of CD22 ligand expression on B and T lymphocytes, and enhanced expression in murine systemic lupus.
Lajaunias F; Ida A; Kikuchi S; Fossati-Jimack L; Martinez-Soria E; Moll T; Law CL; Izui S
Arthritis Rheum; 2003 Jun; 48(6):1612-21. PubMed ID: 12794829
[TBL] [Abstract][Full Text] [Related]
5. The same epitope on CD22 of B lymphocytes mediates the adhesion of erythrocytes, T and B lymphocytes, neutrophils, and monocytes.
Engel P; Nojima Y; Rothstein D; Zhou LJ; Wilson GL; Kehrl JH; Tedder TF
J Immunol; 1993 Jun; 150(11):4719-32. PubMed ID: 7684411
[TBL] [Abstract][Full Text] [Related]
6. Epratuzumab, a humanized monoclonal antibody targeting CD22: characterization of in vitro properties.
Carnahan J; Wang P; Kendall R; Chen C; Hu S; Boone T; Juan T; Talvenheimo J; Montestruque S; Sun J; Elliott G; Thomas J; Ferbas J; Kern B; Briddell R; Leonard JP; Cesano A
Clin Cancer Res; 2003 Sep; 9(10 Pt 2):3982S-90S. PubMed ID: 14506197
[TBL] [Abstract][Full Text] [Related]
7. Ig domains 1 and 2 of murine CD22 constitute the ligand-binding domain and bind multiple sialylated ligands expressed on B and T cells.
Law CL; Aruffo A; Chandran KA; Doty RT; Clark EA
J Immunol; 1995 Oct; 155(7):3368-76. PubMed ID: 7561031
[TBL] [Abstract][Full Text] [Related]
8. CD22 regulates B lymphocyte function in vivo through both ligand-dependent and ligand-independent mechanisms.
Poe JC; Fujimoto Y; Hasegawa M; Haas KM; Miller AS; Sanford IG; Bock CB; Fujimoto M; Tedder TF
Nat Immunol; 2004 Oct; 5(10):1078-87. PubMed ID: 15378059
[TBL] [Abstract][Full Text] [Related]
9. Binding of human plasma sialoglycoproteins by the B cell-specific lectin CD22. Selective recognition of immunoglobulin M and haptoglobin.
Hanasaki K; Powell LD; Varki A
J Biol Chem; 1995 Mar; 270(13):7543-50. PubMed ID: 7706301
[TBL] [Abstract][Full Text] [Related]
10. The oligosaccharide binding specificities of CD22 beta, a sialic acid-specific lectin of B cells.
Powell LD; Varki A
J Biol Chem; 1994 Apr; 269(14):10628-36. PubMed ID: 8144652
[TBL] [Abstract][Full Text] [Related]
11. Masking of CD22 by cis ligands does not prevent redistribution of CD22 to sites of cell contact.
Collins BE; Blixt O; DeSieno AR; Bovin N; Marth JD; Paulson JC
Proc Natl Acad Sci U S A; 2004 Apr; 101(16):6104-9. PubMed ID: 15079087
[TBL] [Abstract][Full Text] [Related]
12. CD22-mediated cell adhesion to cytokine-activated human endothelial cells. Positive and negative regulation by alpha 2-6-sialylation of cellular glycoproteins.
Hanasaki K; Varki A; Powell LD
J Biol Chem; 1995 Mar; 270(13):7533-42. PubMed ID: 7706300
[TBL] [Abstract][Full Text] [Related]
13. Natural ligands of the B cell adhesion molecule CD22 beta can be masked by 9-O-acetylation of sialic acids.
Sjoberg ER; Powell LD; Klein A; Varki A
J Cell Biol; 1994 Jul; 126(2):549-62. PubMed ID: 8034751
[TBL] [Abstract][Full Text] [Related]
14. Masking and unmasking of the sialic acid-binding lectin activity of CD22 (Siglec-2) on B lymphocytes.
Razi N; Varki A
Proc Natl Acad Sci U S A; 1998 Jun; 95(13):7469-74. PubMed ID: 9636173
[TBL] [Abstract][Full Text] [Related]
15. A single N-linked glycosylation site is implicated in the regulation of ligand recognition by the I-type lectins CD22 and CD33.
Sgroi D; Nocks A; Stamenkovic I
J Biol Chem; 1996 Aug; 271(31):18803-9. PubMed ID: 8702538
[TBL] [Abstract][Full Text] [Related]
16. The amino-terminal immunoglobulin-like domain of sialoadhesin contains the sialic acid binding site. Comparison with CD22.
Nath D; van der Merwe PA; Kelm S; Bradfield P; Crocker PR
J Biol Chem; 1995 Nov; 270(44):26184-91. PubMed ID: 7592823
[TBL] [Abstract][Full Text] [Related]
17. Cell surface sialic acids do not affect primary CD22 interactions with CD45 and surface IgM nor the rate of constitutive CD22 endocytosis.
Zhang M; Varki A
Glycobiology; 2004 Nov; 14(11):939-49. PubMed ID: 15240561
[TBL] [Abstract][Full Text] [Related]
18. A comparative study of the asparagine-linked oligosaccharides on siglec-5, siglec-7 and siglec-8, expressed in a CHO cell line, and their contribution to ligand recognition.
Freeman S; Birrell HC; D'Alessio K; Erickson-Miller C; Kikly K; Camilleri P
Eur J Biochem; 2001 Mar; 268(5):1228-37. PubMed ID: 11231274
[TBL] [Abstract][Full Text] [Related]
19. Sialoadhesin, myelin-associated glycoprotein and CD22 define a new family of sialic acid-dependent adhesion molecules of the immunoglobulin superfamily.
Kelm S; Pelz A; Schauer R; Filbin MT; Tang S; de Bellard ME; Schnaar RL; Mahoney JA; Hartnell A; Bradfield P
Curr Biol; 1994 Nov; 4(11):965-72. PubMed ID: 7533044
[TBL] [Abstract][Full Text] [Related]
20. Characterization of sialyloligosaccharide binding by recombinant soluble and native cell-associated CD22. Evidence for a minimal structural recognition motif and the potential importance of multisite binding.
Powell LD; Jain RK; Matta KL; Sabesan S; Varki A
J Biol Chem; 1995 Mar; 270(13):7523-32. PubMed ID: 7706299
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]